Neurofibromatosis type 2.
Publication
, Journal Article
Sathornsumetee, S; DesJardins, A; Reardon, DA; Rich, JN; Vredenburgh, JJ
Published in: Neurology
March 27, 2007
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
March 27, 2007
Volume
68
Issue
13
Start / End Page
E14
Location
United States
Related Subject Headings
- Vestibular Nerve
- Treatment Outcome
- Pyrimidines
- Piperazines
- Neuroma, Acoustic
- Neurology & Neurosurgery
- Neurofibromatosis 2
- Middle Aged
- Magnetic Resonance Imaging
- Imatinib Mesylate
Citation
APA
Chicago
ICMJE
MLA
NLM
Sathornsumetee, S., DesJardins, A., Reardon, D. A., Rich, J. N., & Vredenburgh, J. J. (2007). Neurofibromatosis type 2. Neurology, 68(13), E14. https://doi.org/10.1212/01.wnl.0000257828.56178.9f
Sathornsumetee, S., A. DesJardins, D. A. Reardon, J. N. Rich, and J. J. Vredenburgh. “Neurofibromatosis type 2.” Neurology 68, no. 13 (March 27, 2007): E14. https://doi.org/10.1212/01.wnl.0000257828.56178.9f.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Neurofibromatosis type 2. Neurology. 2007 Mar 27;68(13):E14.
Sathornsumetee, S., et al. “Neurofibromatosis type 2.” Neurology, vol. 68, no. 13, Mar. 2007, p. E14. Pubmed, doi:10.1212/01.wnl.0000257828.56178.9f.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Neurofibromatosis type 2. Neurology. 2007 Mar 27;68(13):E14.
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
March 27, 2007
Volume
68
Issue
13
Start / End Page
E14
Location
United States
Related Subject Headings
- Vestibular Nerve
- Treatment Outcome
- Pyrimidines
- Piperazines
- Neuroma, Acoustic
- Neurology & Neurosurgery
- Neurofibromatosis 2
- Middle Aged
- Magnetic Resonance Imaging
- Imatinib Mesylate